Company intelligence / Profile preview

Decision Options

Princeton, New Jersey, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Decision Options is a specialized technology firm providing AI-driven decision intelligence and predictive analytics for the life sciences, pharmaceutical, and healthcare sectors. The company’s platform utilizes advanced machine learning algorithms to help organizations optimize complex processes such as clinical trial recruitment, market access, and commercial forecasting. By transforming large-scale data into actionable insights, Decision Options enables stakeholders to mitigate risks and improve the efficiency of drug development and delivery. Their expertise spans across revenue management, patient journey mapping, and strategic portfolio optimization.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Decision Options.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Decision Options.

Explore the full profile